Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Treasury Shares (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Treasury Shares for 1 consecutive years, with $71000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed N/A year-over-year to $7.4 million, compared with a TTM value of $7.4 million through Dec 2025, changed N/A, and an annual FY2025 reading of $7.4 million, changed N/A over the prior year.
  • Treasury Shares was $7.4 million for Q4 2025 at Amicus Therapeutics, up from $7390.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $10.4 million in Q2 2023 and bottomed at $7390.0 in Q1 2025.
  • Average Treasury Shares over 5 years is $7.4 million, with a median of $9.5 million recorded in 2024.
  • The sharpest move saw Treasury Shares surged 32.37% in 2022, then tumbled 99.92% in 2025.
  • Year by year, Treasury Shares stood at $7.3 million in 2021, then skyrocketed by 32.37% to $9.7 million in 2022, then grew by 3.25% to $10.0 million in 2023, then fell by 5.78% to $9.5 million in 2024, then fell by 21.82% to $7.4 million in 2025.
  • Business Quant data shows Treasury Shares for FOLD at $71000.0 in Q4 2025, $71000.0 in Q3 2025, and $71000.0 in Q2 2025.